Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

Cited by (999)

Items 201–300 of 999

1. Generation of a Sleeping Beauty Transposon-Based Cellular System for Rapid and Sensitive Screening for Compounds and Cellular Factors Limiting SARS-CoV-2 Replication
   Marek Widera, Alexander Wilhelm, Tuna Toptan, Johanna M. Raffel, Eric Kowarz, Fabian Roesmann, Finn Grözinger, Anna Lena Siemund, Vanessa Luciano, Marius Külp et al. · 2021 · Frontiers in Microbiology
2. Induction of ketosis as a potential therapeutic option to limit hyperglycemia and prevent cytokine storm in COVID-19
   Samir Giuseppe Sukkar, Matteo Bassetti · 2020 · Nutrition
3. Cov-MS: A Community-Based Template Assay for Mass-Spectrometry-Based Protein Detection in SARS-CoV-2 Patients
   Bart Van Puyvelde, Katleen Van Uytfanghe, Olivier Tytgat, Laurence Van Oudenhove, Ralf Gabriels, Robbin Bouwmeester, Simon Daled, Tim Van Den Bossche, Pathmanaban Ramasamy, Sigrid Verhelst et al. · 2021 · JACS Au
4. The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome
   Denise Battaglini, Chiara Robba, Andrea Fedele, Sebastian Trancă, Samir Giuseppe Sukkar, Vincenzo Di Pilato, Matteo Bassetti, Daniele Roberto Giacobbe, Antonio Vena, Nicolo’ Antonino Patroniti et al. · 2021 · Frontiers in Medicine
5. Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection
   Xin Wang, Gang Xu, Xiaoju Liu, Yang Liu, Shuye Zhang, Zheng Zhang · 2021 · Cellular and Molecular Immunology
6. Longitudinal Plasma Proteomics Analysis Reveals Novel Candidate Biomarkers in Acute COVID-19
   Yassene Mohammed, David R. Goodlett, Matthew Pellan Cheng, Donald Cuong Vinh, Todd Campbell Lee, Allison McGeer, David D. Sweet, Karen C. Tran, Terry Lee, Srinivas Murthy et al. · 2022 · Journal of Proteome Research
7. SARS-CoV-2 ORF10 impairs cilia by enhancing CUL2ZYG11B activity
   Liying Wang, Chao Liu, Bo Yang, Haotian Zhang, Jian Jiao, Ruidan Zhang, Shujun Liu, Sai Jin Xiao, Yinghong Chen, Bo Liu et al. · 2022 · The Journal of Cell Biology
8. Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2
   Lucia Lisi, Pedro Miguel Lacal, Maria Luisa Barbaccia, Grazia Graziani · 2020 · Biochemical Pharmacology
9. Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells
   Richard Schäfer, Gabriele Spohn, Marco Bechtel, Denisa Bojková, Patrick C. Baer, Selim Kuçi, Erhard Seifried, Sandra Ciesek, Jindrich Jr. Cinatl · 2020 · Stem Cell Reports
10. Ipomoeassin-F inhibits the in vitro biogenesis of the SARS-CoV-2 spike protein and its host cell membrane receptor
    Sarah O’Keefe, Peristera Roboti, Kwabena B. Duah, Guanghui Zong, Hayden O. Schneider, Wei Q. Shi, Stephen High · 2021 · Journal of Cell Science
11. Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro
    Matthew H. Raymonda, Jessica H. Ciesla, Morgan Monaghan, Justin R. Leach, Gloria Asantewaa, Leonid Smorodintsev-Schiller, Michael M. Lutz, Xenia Schafer, Toru Takimoto, Stephen Dewhurst et al. · 2021 · Virology
12. A Comprehensive Biological and Synthetic Perspective on 2-Deoxy- d -Glucose (2-DG), A Sweet Molecule with Therapeutic and Diagnostic Potentials
    Yasanandana Supunsiri Wijayasinghe, Meenakshi P. Bhansali, Maheshkumar R. Borkar, Ganesh Ulhasrao Chaturbhuj, Brian S. Muntean, Ronald E. Viola, Pravin R. Bhansali · 2022 · Journal of Medicinal Chemistry
13. Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
    Matthew D. Hall, James Melvin Anderson, Annaliesa S. Anderson, David A. Baker, James E. Bradner, Kyle R. Brimacombe, Elizabeth A. Campbell, Kizzmekia S. Corbett, Kara L. Carter, Sara R. Cherry et al. · 2021 · The Journal of Infectious Diseases
14. Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion
    Tabea M. Eser, Olga Baranov, Manuel Huth, Mohammed I. M. Ahmed, Flora Deák, Kathrin Held, Luming Lin, Kami Pekayvaz, Alexander Leunig, Leo Nicolai et al. · 2023 · Nature Communications
15. Primed for global coronavirus pandemic: Emerging research and clinical outcome
    Shakir Ahamad, Scotty Branch, Shea Harrelson, Mohd Kamil Hussain, Mohammad Saquib, Saeed Khan · 2020 · European Journal of Medicinal Chemistry
16. Spike protein of SARS‐CoV‐2 activates macrophages and contributes to induction of acute lung inflammation in male mice
    Xiaoling Cao, Yan Tian, Vi Nguyen, Yuping Zhang, Chao Gao, Rong L. Yin, Wayne E. Carver, Daping Fan, Helmut Albrecht, Taixing Cui et al. · 2021 · The FASEB Journal
17. Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences
    Suvankar Banerjee, Sandip Kumar Baidya, Nilanjan Adhikari, Balaram Ghosh, Tarun Jha · 2022 · Journal of Molecular Structure
18. A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management
    Amit Verma, Amitava Adhikary, Gayle E. Woloschak, Bilikere Srinivasa Rao Dwarakanath, Rao V. L. Papineni · 2020 · International Journal of Radiation Biology
19. Targeted Down Regulation Of Core Mitochondrial Genes During SARS-CoV-2 Infection
    Joseph W. Guarnieri, Joseph M. Dybas, Hossein Fazelinia, Man Soo Kim, Justin J. Frere, Yuanchao Zhang, Yentli E. Soto Albrecht, Deborah G. Murdock, Alessia Angelin, Larry N. Singh et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
20. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?
    Vijay Kumar · 2020 · International Reviews of Immunology
21. 2-Deoxy-D-Glucose: A Novel Pharmacological Agent for Killing Hypoxic Tumor Cells, Oxygen Dependence-Lowering in Covid-19, and Other Pharmacological Activities
    Raman Singh, Vidushi Gupta, Antresh Kumar, Kuldeep Singh · 2023 · Advances in Pharmacological and Pharmaceutical Sciences
22. Mitochondrial antioxidants abate SARS-COV-2 pathology in mice
    Joseph W. Guarnieri, Timothy Lie, Yentli E. Soto Albrecht, Peter Hewin, Kellie A. Jurado, Gabrielle A. Widjaja, Yi Zhu, Meagan J. McManus, Todd J. Kilbaugh, Kelsey Keith et al. · 2024 · Proceedings of the National Academy of Sciences
23. SARS-CoV-2 remodels the Golgi apparatus to facilitate viral assembly and secretion
    Jianchao Zhang, Andrew A. Kennedy, Daniel Macedo de Melo Jorge, Lijuan Xing, Whitney Reid, Sarah Bui, Joseph Joppich, Molly Rose, Sevval Ercan, Qiyi Tang et al. · 2025 · PLoS Pathogens
24. Mass spectrometry analytical responses to the SARS-CoV2 coronavirus in review
    Justin H. Griffin, Kevin M. Downard · 2021 · TrAC Trends in Analytical Chemistry
25. Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19
    Chong Wang, Xufang Li, Wanshan Ning, Sitang Gong, Fengxia Yang, Chunxiao Fang, Yu Gong, Di Wu, Muhan Huang, Yujie Gou et al. · 2021 · Theranostics
26. The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D-Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic Viruses
    Beata Pająk, Rafal J. Zielinski, John Tyler Manning, Stanislava Matejin, Slobodan Paessler, Izabela Fokt, Mark R. Emmett, Waldemar Priebe · 2022 · Molecules
27. Clinical manifestation, outcomes in pregnant women with COVID-19 and the possibility of vertical transmission: a systematic review of the current data
    Yu Kyeong Han, Huijing Ma, Mingli Suo, Fang Han, Fang Wang, Jingru Ji, Jing Ji, Hailan Yang · 2020 · Journal of Perinatal Medicine
28. IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals
    Mary Kathryn Bohn, Giuseppe Lippi, Andrea Rita Horvath, Rajiv Timothy Erasmus, Matthias Grimmler, Maurizio Gramegna, Nicasio Mancini, Robert Mueller, William D. Rawlinson, María Elizabeth Menezes et al. · 2021 · Clinical Chemistry and Laboratory Medicine (CCLM)
29. Cellular metabolism hijacked by viruses for immunoevasion: potential antiviral targets
    Jiaqi Li, Yanjin Wang, Hao Deng, Li Su, Hua‐Ji Qiu · 2023 · Frontiers in Immunology
30. Virus‐induced host cell metabolic alteration
    Syed Shahariar Bappy, Md. Muzammal Haque Asim, Mohammad Mainul Ahasan, Asif Ahsan, Sorna Sultana, Roksana Khanam, Abu Zaffar Shibly, Yearul Kabir · 2024 · Reviews in Medical Virology
31. A new paradigm for drug discovery in the treatment of complex diseases: drug discovery and optimization
    Yu Yuan, Lu-Lu Yu, Chenghao Bi, Liping Huang, Buda Su, Jiaxuan Nie, Zhiying Dou, Shenshen Yang, Yubo Li · 2025 · Chinese Medicine
32. COVID-19-Related Coagulopathy—Is Transferrin a Missing Link?
    Katie-May McLaughlin, M. Bechtel, D. Bojkova, C. Münch, S. Ciesek, M. Wass, M. Michaelis, J. Cinatl · 2020 · bioRxiv
33. SARS‐CoV‐2 infection remodels the host protein thermal stability landscape
    Joel Selkrig, Megan Lynn Stanifer, André Mateus, Karin Mitosch, Inigo Barrio‐Hernandez, Mandy Rettel, Heeyoung Kim, Carlos Geert Pieter Voogdt, Philipp Walch, Carmon Kee et al. · 2021 · Molecular Systems Biology
34. Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes
    Fabrizio Maggi, Alfredo Rosellini, Pietro Giorgio Spezia, Daniele Focosi, Lisa Macera, Michele Lai, Mauro Pistello, Antonio de Iure, Carlo Tomino, Stefano Bonassi et al. · 2021 · ERJ Open Research
35. SARS-CoV-2 Infection Remodels the Phenotype and Promotes Angiogenesis of Primary Human Lung Endothelial Cells
    Francesca Caccuri, Antonella Bugatti, Alberto Zani, Antonella De Palma, Dario Di Silvestre, Ekta Manocha, Federica Filippini, Serena Messali, Paola Chiodelli, Giovanni Campisi et al. · 2021 · Microorganisms
36. Different Aspects of Emetine’s Capabilities as a Highly Potent SARS-CoV-2 Inhibitor against COVID-19
    Mehdi Valipour · 2022 · ACS Pharmacology & Translational Science
37. Gastrointestinal involvement attenuates COVID-19 severity and mortality
    Alexandra E. Livanos, Divya Jha, Francesca Cossarini, Ana Silvia Gonzalez-Reiche, Minami A. Tokuyama, Teresa Aydillo, Tommaso Lorenzo Parigi, Irene Ramos, Katie A. Dunleavy, Brian Hyohyoung Lee et al. · 2020 · medRxiv
38. Combined assessment of MHC binding and antigen abundance improves T cell epitope predictions
    Zeynep Koşaloğlu‐Yalçın, Jenny Lee, Jason Greenbaum, Stephen Philip Schoenberger, Aaron M. Miller, Young Jin Kim, Alessandro Sette, Morten Nielsen, Bjoern Peters · 2022 · iScience
39. The Orf9b protein of SARS-CoV-2 modulates mitochondrial protein biogenesis
    Svenja Lenhard, Sarah Gerlich, Azkia Khan, Saskia Rödl, Jan-Eric Bökenkamp, Esra Peker, C. Zarges, J. Faust, Z. Storchová, M. Räschle et al. · 2023 · Journal of Cell Biology
40. SARS-CoV-2 Codon Usage Bias Downregulates Host Expressed Genes With Similar Codon Usage
    Andrés M. Alonso, Luis Anibal Diambra · 2020 · Frontiers in Cell and Developmental Biology
41. Recent Insights into Emerging Coronavirus: SARS-CoV-2
    Zifang Shang, Siew Yin Chan, William J. Liu, Peng Li, Wei Huang · 2020 · ACS Infectious Diseases
42. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology
    Paige Haas, Monita Muralidharan, Nevan J. Krogan, Robyn M. Kaake, Ruth Hüttenhain · 2021 · Journal of Proteome Research
43. Clocks, Viruses, and Immunity: Lessons for the COVID-19 Pandemic
    Shaon Sengupta, Louise Madeleine Ince, Francesca Sartor, Helene Borrmann, Xiaodong Alan Zhuang, Amruta S. Naik, Annie M. Curtis, Jane A. McKeating · 2021 · Journal of Biological Rhythms
44. An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19
    Julia Y. Wang, Wei Zhang, Michael H. A. Roehrl, Victor B. Roehrl, Michael H. A. Roehrl · 2021 · Journal of Autoimmunity
45. Impact of computational approaches in the fight against COVID-19: an AI guided review of 17 000 studies
    Francesco Napolitano, Xiaopeng Xu, Xin Gao · 2021 · Briefings in Bioinformatics
46. SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis
    Jun‐yi Zhu, Guanglei Wang, Xiaohu Huang, Hangnoh Lee, Jin‐Gu Lee, Penghua Yang, Joyce van de Leemput, Weiliang Huang, Maureen A. Kane, Peixin Yang et al. · 2022 · Communications Biology
47. Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence
    Jack Gisby, Norzawani B Buang, Artemis Papadaki, Candice Clarke, Talat H. Malik, Nicholas Medjeral‐Thomas, Damiola Pinheiro, Paige M Mortimer, Shanice Lewis, Eleanor Sandhu et al. · 2022 · Nature Communications
48. Role of Multiomics Data to Understand Host–Pathogen Interactions in COVID-19 Pathogenesis
    Shalini Aggarwal, Arup Acharjee, Amrita Mukherjee, Mark S. Baker, Sanjeeva Srivastava · 2021 · Journal of Proteome Research
49. ORF10–Cullin-2–ZYG11B complex is not required for SARS-CoV-2 infection
    Elijah L. Mena, Callie J. Donahue, Laura Pontano Vaites, Jie Li, Gergely Róna, Colin O’Leary, Luca Lignitto, Bearach Miwatani-Minter, João A. Paulo, Avantika Dhabaria et al. · 2021 · Proceedings of the National Academy of Sciences
50. Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus
    Xiaoqin Zheng, Zeyu Sun, Liang Yu, Danrong Shi, Miaojin Zhu, Hangping Yao, Lanjuan Li · 2021 · Pathogens
51. Proteome-wide data analysis reveals tissue-specific network associated with SARS-CoV-2 infection
    Li Feng, Yuan-Yuan Yin, Conghui Liu, Keren Xu, Qingrun Li, Jiarui Wu, Rong Zeng · 2020 · Journal of Molecular Cell Biology
52. Intermolecular Interaction Among Remdesivir, RNA and RNA-Dependent RNA Polymerase of SARS-CoV-2 Analyzed by Fragment Molecular Orbital Calculation
    Koichiro Kato, Teruki Honma, Kaori Fukuzawa · 2020 · Journal of Molecular Graphics and Modelling
53. “A Chain Only as Strong as Its Weakest Link”: An Up-to-Date Literature Review on the Bidirectional Interaction of Pulmonary Fibrosis and COVID-19
    Radu Adrian Crișan-Dabija, Cristina-Alice Pavel, Iolanda Valentina Popa, Andrei Țăruș, Alexandru Burlacu · 2020 · Journal of Proteome Research
54. A Computer-Aided Drug Design Approach to Predict Marine Drug-Like Leads for SARS-CoV-2 Main Protease Inhibition
    Susana P. Gaudêncio, Florbela Pereira · 2020 · Marine Drugs
55. Proteomic investigation reveals dominant alterations of neutrophil degranulation and mRNA translation pathways in patients with COVID-19
    Renuka Bankar, Kruthi Suvarna, Saicharan Ghantasala, Arghya Banerjee, Deeptarup Biswas, Manisha Choudhury, Viswanthram Palanivel, Akanksha Salkar, Ayushi Verma, Avinash Kumar Singh et al. · 2021 · iScience
56. Molecular mechanisms of Na,K-ATPase dysregulation driving alveolar epithelial barrier failure in severe COVID-19
    Vitalii Kryvenko, István Vadász · 2021 · American Journal of Physiology-Lung Cellular and Molecular Physiology
57. Differential host circRNA expression profiles in human lung epithelial cells infected with SARS-CoV-2
    Mengmei Yang, Mengdi Qi, Liangzi Xu, Pu Huang, Xu Wang, Jing Sun, Jiandong Shi, Yunzhang Hu · 2021 · Infection Genetics and Evolution
58. Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections
    Aleksandr Ianevski, Rouan Yao, Eva Žusinaite, Laura Sandra Lello, Sainan Wang, Eunji Jo, Jaewon Yang, Erlend Ravlo, Wei Wang, Hilde Lysvand et al. · 2021 · Viruses
59. A glucose-like metabolite deficient in diabetes inhibits cellular entry of SARS-CoV-2
    Liangqin Tong, Xiaoping Xiao, Min Li, Shisong Fang, Enhao Ma, Xi Yu, Yibin Zhu, Chunli Wu, Deyu Tian, Fan Yang et al. · 2022 · Nature Metabolism
60. Active conformation of the p97-p47 unfoldase complex
    Yang Jian Xu, Han Han, Ian Cooney, Yuxuan Guo, Noah G. Moran, Nathan R. Zuniga, John C. Price, Christopher P. Hill, Peter S Shen · 2022 · Nature Communications
61. Spatial region-resolved proteome map reveals mechanism of COVID-19-associated heart injury
    Ling Leng, Ma J, Peipei Zhang, Si‐Chi Xu, Xiao Li, Ye Hwa Jin, Jun Cai, Rui Tang, Lei Zhao, Zhicheng He et al. · 2022 · Cell Reports
62. Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
    Kunal Nepali, Ram Lal Sharma, Sachin Sharma, Amandeep Thakur, Jing‐Ping Liou · 2022 · Journal of Biomedical Science
63. Predicting COVID-19—Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management
    Debmalya Barh, Alaa A. A. Aljabali, Murtaza M. Tambuwala, Sandeep Tiwari, Ángel Serrano‐Aroca, Khalid Jamaan Alzahrani, Bruno Silva Andrade, Vasco Azevedo, Nirmal Kumar Ganguly, Kenneth H. Lundstrom · 2021 · Biomedicines
64. 14-3-3 Proteins are Potential Regulators of Liquid–Liquid Phase Separation
    Xianlong Huang, Zhiwen Zheng, Yixin Wu, Meng Gao, Zhengding Su, Yongqi Huang · 2022 · Cell Biochemistry and Biophysics
65. Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach
    Andreas Wasilewicz, Benjamin Kirchweger, Denisa Bojková, Marie Jose Abi Saad, Julia Langeder, Matthias Bütikofer, Sigrid Adelsberger, Ulrike Grienke, Jindrich Jr. Cinatl, Olivier Petermann et al. · 2023 · Journal of Natural Products
66. Molecular Insights on the Possible Role of Annexin A2 in COVID-19 Pathogenesis and Post-Infection Complications
    Prakash Patil, Praveenkumar K. Shetty, Nithin Kuriakose, Pavan Gollapalli, Sukanya Shetty, Roopa Rani Bhandary, Jamboor K. Vishwanatha, Sudeep Darbhe Ghate · 2021 · International Journal of Molecular Sciences
67. Complement factor D targeting protects endotheliopathy in organoid and monkey models of COVID-19
    Eri Kawakami, Norikazu Saiki, Yosuke Yoneyama, Chiharu Moriya, Mari Maezawa, Shuntaro Kawamura, Akiko Kinebuchi, Tamaki Kono, Masaaki Funata, Ayaka Sakoda et al. · 2023 · Cell stem cell
68. Advances in the computational landscape for repurposed drugs against COVID-19
    Illya Aronskyy, Yosef Masoudi‐Sobhanzadeh, Antonio Cappuccio, Elena Zaslavsky · 2021 · Drug Discovery Today
69. SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication
    Christina A. Higgins, Benjamin E. Nilsson-Payant, Andrew P. Kurland, Chengjin Ye, Томер Ярон, Jared Lee Johnson, Boris Bonaventure, Prithy Adhikary, Ilona Golynker, Maryline Panis et al. · 2023 · mBio
70. Non-canonical function of histone methyltransferase G9a in the translational regulation of chronic inflammation
    Adil Muneer, Li Wang, Ling Xie, Feng Zhang, Bing Wu, Mei Liu, Erik M. Lenarcic, Emerald Hillary Feng, Juan Song, Yan Xiong et al. · 2023 · Cell chemical biology
71. The European Bioinformatics Institute: empowering cooperation in response to a global health crisis
    Gaia Cantelli, Guy Cochrane, Cath Brooksbank, Ellen M. McDonagh, Paul Flicek, Johanna McEntyre, Ewan Birney, Rolf Apweiler · 2020 · Nucleic Acids Research
72. A review of COVID-19 biomarkers and drug targets: resources and tools
    Francesca Pia Caruso, Giovanni Scala, Luigi Cerulo, Michele Ceccarelli · 2020 · Briefings in Bioinformatics
73. Experimental Models of SARS-CoV-2 Infection: Possible Platforms to Study COVID-19 Pathogenesis and Potential Treatments
    Sareh Pandamooz, Benjamin Jurek, Carl-Philipp Meinung, Zahra Baharvand, Alireza Sahebi Shahem-abadi, Silke Haerteis, Jaleel A. Miyan, James R. Downing, Mehdi Dianatpour, Afshin Borhani‐Haghighi et al. · 2021 · The Annual Review of Pharmacology and Toxicology
74. An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19
    Julia Y. Wang, Wei jin Zhang, Michael H. A. Roehrl, Michael H. A. Roehrl, Michael H. A. Roehrl · 2022 · Frontiers in Immunology
75. A Retinol Derivative Inhibits SARS-CoV-2 Infection by Interrupting Spike-Mediated Cellular Entry
    Liangqin Tong, Lin Wang, Shumin Liao, Xiaoping Xiao, Jing Tao Qu, Chunli Wu, Yibin Zhu, Wanbo Tai, Yanhong Huang, Penghua Wang et al. · 2022 · mBio
76. Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly
    Émilie Murigneux, Laurent Softic, Corentin Aubé, Carmen Grandi, Delphine Judith, Johanna Bruce, Morgane Le Gall, François Guillonneau, Alain Schmitt, Vincent Parissi et al. · 2024 · Nature Communications
77. SARS-CoV-2 activates ER stress and Unfolded protein response
    Lívia Rosa-Fernandes, Lucas Cardoso Lázari, Janaína Macedo da Silva, Vinícius M. Gomes, Rafael Rahal Guaragna Machado, Ancély Ferreira dos Santos, Danielle Bastos Araújo, João Vitor Paccini Coutinho, Gabriel Santos Arini, Cláudia Blanes Angeli et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
78. Aptamers for Detection and Diagnostics (ADD): Can mobile systems process optical data from aptamer sensors to identify molecules indicating presence of SARS-CoV-2 virus? Should healthcare explore aptamers as drugs for prevention as well as its use as adjuvants with antibodies and vaccines?
    Shoumen Datta · 2020 · ChemRxiv
79. Newcastle Disease Virus Manipulates Mitochondrial MTHFD2-Mediated Nucleotide Metabolism for Virus Replication
    Ning Tang, Pingyi Chen, Changrun Zhao, Panrao Liu, Lei Tan, Cuiping Song, Xusheng Qiu, Ying Liao, Xiufan Liu, Tingrong Luo et al. · 2023 · Journal of Virology
80. Association between cardiometabolic risk factors and COVID-19 susceptibility, severity and mortality: a review
    Yasaman Sharifi, Moloud Payab, Erfan Mohammadi‐Vajari, Seyed Morsal Mosallami Aghili, Farshad Sharifi, Neda Mehrdad, Elham Kashani, Zhaleh Shadman, Bagher A. Larijani, Mahbube Ebrahimpur · 2021 · Journal of Diabetes & Metabolic Disorders
81. Metabolic Modifications by Common Respiratory Viruses and Their Potential as New Antiviral Targets
    Jens Kleinehr, Janine J. Wilden, Yvonne Boergeling, Stephan Ludwig, Eike Roman Hrincius · 2021 · Viruses
82. The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response
    Francisco J. Enguita, Ana Lúcia Leitão, John Tyson McDonald, Victoria Zaksas, Saswati Das, Diego Galeano, Deanne M. Taylor, Eve Syrkin Wurtele, Amanda Saravia-Butler, Stephen B. Baylin et al. · 2022 · Theranostics
83. Recent trends on omics and bioinformatics approaches to study SARS-CoV-2: A bibliometric analysis and mini-review
    Julieth Murillo, Lina María Villegas-Trujillo, Leidy Marcela Ulloa-Murillo, Alejandra Rodríguez · 2020 · Computers in Biology and Medicine
84. SARS-COV-2 infection and lung tumor microenvironment
    Naila Malkani, Muhammad Usman Rashid · 2021 · Molecular Biology Reports
85. Mass spectrometry‐based proteomic platforms for better understanding of SARS‐CoV‐2 induced pathogenesis and potential diagnostic approaches
    Nagib Ahsan, R. Shyama Prasad Rao, Rashaun S. Wilson, Ujwal Punyamurtula, Fernanda Salvato, Max Petersen, Mohammad Kabir Ahmed, Md. Ruhul Abid, Jacob C. Verburgt, Daisuke Kihara et al. · 2021 · PROTEOMICS
86. Proteomics and metabonomics analyses of Covid-19 complications in patients with pulmonary fibrosis
    Jianrong Yang, Chunxia Chen, Wan Chen, Luying Huang, Zhao Fu, Kun Ye, Liwen Lv, Zhihuang Nong, Xing Zhou, Wensheng Lu et al. · 2021 · Scientific Reports
87. A Monoclonal Human Alveolar Epithelial Cell Line (“Arlo”) with Pronounced Barrier Function for Studying Drug Permeability and Viral Infections
    Patrick Carius, Annemarie Jungmann, Marco Bechtel, Alexander Grißmer, Annette S. Boese, Gilles Gasparoni, Abdulrahman Salhab, Ralf G. Seipelt, Klaus Urbschat, Clémentine Richter et al. · 2023 · Advanced Science
88. Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus Infections
    Qiongqiong Angela Zhou, Junko Kato-Weinstein, Yingzhu Li, Yi Deng, Roger Granet, Linda V. Garner, Cynthia Liu, Dmitrii A. Polshakov, Chris Gessner, Steven Watkins · 2020 · ACS Pharmacology & Translational Science
89. Endothelial metabolism in pulmonary vascular homeostasis and acute respiratory distress syndrome
    Reece P. Stevens, Sunita S. Paudel, Santina Johnson, Troy Stevens, Ji Lee · 2021 · American Journal of Physiology-Lung Cellular and Molecular Physiology
90. DIA-Based Proteome Profiling of Nasopharyngeal Swabs from COVID-19 Patients
    Dong‐Gi Mun, Patrick M. Vanderboom, Anil Kumar Madugundu, Kishore Garapati, Sandip Chavan, Jane A. Peterson, Mayank Saraswat, Akhilesh Pandey · 2021 · Journal of Proteome Research
91. Discovery Proteomics for COVID-19: Where We Are Now
    Angela McArdle, Kirstin E. Washington, Blandine Chazarin, Aleksandra Binek, Danica-Mae Manalo, Alejandro Rivas, Matthew Ayres, Rakhi Pandey, Connor Phebus, Koen Raedschelders et al. · 2021 · Journal of Proteome Research
92. Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection
    Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Hatem Zayed, Sang‐Soo Lee · 2021 · Frontiers in Immunology
93. Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review)
    Yingshuang Li, Hua-Cheng Ren, Jian-Hua Cao · 2022 · International Journal of Oncology
94. Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
    Raahilah Zahir Essa, Yuan Seng Wu, Kalaivani Batumalaie, Mahendran Sekar, Chit Laa Poh · 2022 · Pharmacological Reports
95. Towards systems immunology of critical illness at scale: from single cell ‘omics to digital twins
    Yoram Vodovotz B · 2023 · Trends in Immunology
96. Exploring the Therapeutic Potential of Petiveria alliacea L. Phytochemicals: A Computational Study on Inhibiting SARS-CoV-2’s Main Protease (Mpro)
    Md. Ahad Ali, Humaira Sheikh, Muhammad Yaseen, Md Omar Faruqe, Ihsan Ullah, Neeraj Kumar, M. A. Bhat, Md. Nurul Haque Mollah · 2024 · Molecules
97. Impact of Gastrointestinal Symptoms in COVID-19: a Molecular Approach
    Charu Sonkar, Dharmendra Kashyap, Nidhi Varshney, Budhadev Baral, Hem Chandra Jha · 2020 · SN Comprehensive Clinical Medicine
98. A novel multi-omics-based highly accurate prediction of symptoms, comorbid conditions, and possible long-term complications of COVID-19
    Debmalya Barh, Sandeep Tiwari, Bruno Silva Andrade, Marianna E. Weener, Aristóteles Goés‐Neto, Vasco Azevedo, Preetam Ghosh, Kenneth Blum, Nirmal Kumar Ganguly · 2021 · Molecular Omics
99. Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells
    Xuefeng Wang, Yudong Zhao, Feihu Yan, Tiecheng Wang, Weiyang Sun, Na Feng, Wenqi Wang, Hongmei Wang, Hongbin He, Songtao Yang et al. · 2021 · Journal of Virology
100. Predicted coronavirus Nsp5 protease cleavage sites in the human proteome
     Benjamin M. Scott, Vincent Lacasse, Ditte G. Blom, Peter D. Tonner, Nikolaj Blom · 2022 · BMC Genomic Data